Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesIs malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies
European Journal of Cardio-Thoracic Surgery, 10/14/09
Trousse DS et al. – The results concur with the published data of the most experienced centre with regards to the mortality and morbidity after EPP for MPM. In line with the biggest series reported in the past, the observed 5–year survival rate of almost 15% is disappointing.
Related Articles
Molecular Targets in Malignant Pleural Mesothelioma Treatment
Current Drug Targets, 11/10/09
Relevance Score: 92%
Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis
Pathology International, 10/20/09
Relevance Score: 92%
Solitary Fibrous Tumors of the Pleura: An Analysis of 110 Patients Treated in a Single Institution
Annals of Thoracic Surgery, 10/23/09
Relevance Score: 88%
Solitary fibrous tumor of the thyroid gland
The Laryngoscope, 10/07/09
Relevance Score: 82%
Giant Cell Angiofibroma, A Variant of Solitary Fibrous Tumor, of the Orbit in a 16-Year-Old Girl
Ophthalmic Plastic and Reconstructive Surgery, 10/07/09
Relevance Score: 81%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
A small-cell lung cancer genome with complex signatures of tobacco exposure
Nature, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor